Finance

Lists
ERIS:NSE
Eris Lifesciences Ltd
₹1,155.00
-0.18%
(-2.10) 1D
Oct 13, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ERIS...
Open
₹1,155.00
High
₹1,158.70
Low
₹1,142.20
Mkt. cap
160.24B
Avg. vol.
108.16K
Volume
41.11K
Dividend
0.62%
Quarterly dividend
₹1.80
Ex-dividend date
Feb 13, 2025
P/E ratio
24.71
52-wk high
₹1,740.00
52-wk low
₹1,141.00
EPS
₹46.75
Shares outstanding
137.52M
No. of employees
3K
Open
₹1,155.00
High
₹1,158.70
Low
₹1,142.20
Mkt. cap
160.24B
Avg. vol.
108.16K
Volume
41.11K
Dividend
0.62%
Quarterly dividend
₹1.80
Ex-dividend date
Feb 13, 2025
P/E ratio
24.71
52-wk high
₹1,740.00
52-wk low
₹1,141.00
EPS
₹46.75
Shares outstanding
137.52M
No. of employees
3K
News stories
From web sources and news partners
About Eris Lifesciences Ltd
CEO-
Employees2.76K
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteeris.co.in
Last report
Jul 29, 2026
Fiscal period
Q1 2027
₹10.26 / ₹10.77
-4.71%miss
Revenue / Est. (INR)
8.69B / 8.57B
+1.43%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.90B
8.01B
7.52B
8.69B
Cost of goods sold
2.02B
2.23B
2.10B
2.39B
Cost of revenue
2.02B
2.23B
2.10B
2.39B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.37B
1.38B
1.52B
1.53B
Operating expense
3.69B
3.66B
3.38B
4.06B
Total operating expenses
5.71B
5.90B
5.48B
6.45B
Operating income
2.19B
2.11B
2.04B
2.24B
Other non operating income
28.10M
200.00K
-19.40M
23.90M
EBT including unusual items
1.73B
1.45B
1.59B
1.79B
EBT excluding unusual items
1.73B
1.63B
1.59B
1.79B
Income tax expense
382.00M
365.20M
-1.20B
361.70M
Effective tax rate
22.12%
25.13%
-75.08%
20.15%
Other operating expenses
1.62B
1.58B
1.16B
1.80B
Net income
1.20B
997.20M
2.82B
1.42B
Net profit margin
15.21%
12.45%
37.44%
16.38%
Earnings per share
8.81
8.26
20.57
10.26
Interest and investment income
-
-
34.70M
-
Interest expense
-495.50M
-488.20M
-456.00M
-466.50M
Net interest expenses
-495.50M
-488.20M
-421.30M
-466.50M
Depreciation and amortization charges
690.80M
703.40M
695.70M
720.70M
EBITDA
2.89B
2.87B
2.70B
2.94B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps